Search

Displaying results 4111 - 4120 of 8412 in total
  1. Drug

    AMG 108

    go.drugbank.com/drugs/DB05545
    Investigational

    AMG 108 was investigated for use as an antirheumatic agent.

  2. Drug

    Matrix-M

    go.drugbank.com/drugs/DB16369
    Investigational

    Matrix-M is a saponin-based adjuvant made of nanometer particles, cholesterol, and phospholipid that is developed by Novavax. This compound is administered alongside vaccines to enhance biological functions: creating robust and long-last...

  3. Drug

    Nesvategrast

    go.drugbank.com/drugs/DB19337
    Investigational

    Nesvategrast is under investigation in clinical trial NCT05409235 (Nesvategrast (OTT166) in Diabetic Retinopathy (DR)).

  4. Drug

    Taribavirin

    go.drugbank.com/drugs/DB06408
    Investigational

  5. Drug

    Pridinol

    go.drugbank.com/drugs/DB13642
    Investigational

    Mixtures: DIOXAFLEX DUO
  6. Drug

    Phenothrin

    go.drugbank.com/drugs/DB13717
    Investigational

    Mixtures: HERKLIN CLÁSICO-DUO
  7. Drug

    Erdosteine

    go.drugbank.com/drugs/DB05057
    ApprovedInvestigational

    Erdosteine is a drug that causes a breakdown of mucus, also known as a mucolytic agent. It is a thiol derivative produced for the clinical management of chronic obstructive bronchitis, in addition to infective exacerbations of chronic br...

  8. Drug

    Rebastinib

    go.drugbank.com/drugs/DB13005
    Investigational

    It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.

  9. Drug

    Elacytarabine

    go.drugbank.com/drugs/DB05494
    Investigational

    Elacytarabine is a fatty acid derivative of [cytarabine], an approved cytotoxic cancer drug. Cytarabine has limitations such as minimal uptake in solid tumours and is only used to treat leukaemia.

  10. Drug

    Concanamycin A

    go.drugbank.com/drugs/DB14062
    Experimental

    Concanamycin A is an H+-ATPase (vacuolar) inhibitor.

    Categories: P-glycoprotein inhibitors